Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NSTG +9.2% (guidance), U +5.9% (guidance and Chairman and CEO retiring), HON +1.3% (guidance), PEP +0.8%
Other news:
- COHR +12.7% (announced that Denso (DNZOY) and Mitsubishi Electric (MIELY) have agreed to invest $1 billion in its silicon carbide business; COHR narrows Q1 revs guidance)
- LXRX +9% (INPEFA receives preferred formulary status)
- H +5.4% (replacing NATI in the S&P MidCap 400)
- PSTX +4.4% (appoints new Chairman and CEO)
- OCS +2.4% (phase 3 stage 1 DIAMOND trial results of OCS-01)
- STLA +2.3% (announces additional 570 employees on layoff)
- NNDM +2.2% (stated that business functions as usual)
- OLMA +1.9% (announces an amendment to existing clinical collaboration and supply agreement with Novartis)
- BKD +1.6% (reports September 2023 occupancy)
- AOS +1.5% (increases dividend)
- AL +1.2% (announced an update on aircraft investments and sales activities occurring in the third quarter of 2023)
- KMDA +1.2% (continues to conduct its business operations in Israel with no effect on business continuity and its global supply of products is not expected to be interrupted)
- HUT +1% (reports Sept metrics)
Analyst comments:
- ACAD +4% (upgraded to Overweight from Neutral at JP Morgan)
- RIVN +3.2% (upgraded to Buy from Neutral at UBS)
- EA +1.8% (upgraded to Buy from Neutral at BofA Securities)
- SBRA +1.8% (upgraded to Buy from Neutral at BofA Securities)